UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 465

Sortiert nach

Vulval squamous cell carcinoma and its precursors

Histopathology, 2020-01, Vol.76 (1), p.128-138

2020

Volltextzugriff (PDF)

Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020)

Histopathology, 2022-04, Vol.80 (5), p.762-778

2022

Volltextzugriff (PDF)

Dr. Naveena Singh, Dec 7 1964 - Oct 5 2023

Histopathology, 2024-01, Vol.84 (2), p.416-417

2024

Volltextzugriff (PDF)

Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis

The Journal of pathology, 2021-04, Vol.253 (4), p.355-365

2021

Volltextzugriff (PDF)

Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists

International journal of gynecological pathology, 2019-01, Vol.38 Suppl 1, p.S64

2019

Volltextzugriff (PDF)

L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile

British journal of cancer, 2018-08, Vol.119 (4), p.480-486

2018

Volltextzugriff (PDF)

Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma

The American journal of surgical pathology, 2013-06, Vol.37 (6), p.874-881

2013

Volltextzugriff (PDF)

The disparate origins of ovarian cancers: pathogenesis and prevention strategies

Nature reviews. Cancer, 2017-01, Vol.17 (1), p.65

2017

Volltextzugriff (PDF)

Ovarian carcinoma pathology and genetics: recent advances

Human pathology, 2009-09, Vol.40 (9), p.1213-1223

2009

Volltextzugriff (PDF)

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies

The Journal of pathology, 2020-03, Vol.250 (3), p.336-345

2020

Volltextzugriff (PDF)

Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma

Clinical cancer research, 2019-04, Vol.25 (8), p.2537-2548

2019

Volltextzugriff (PDF)

Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes

Nature communications, 2022-02, Vol.13 (1), p.896-896, Article 896

2022

Volltextzugriff (PDF)

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

The Journal of pathology, 2020-03, Vol.250 (3), p.312-322

2020

Volltextzugriff (PDF)

Interpretation of somatic POLE mutations in endometrial carcinoma

The Journal of pathology, 2020-03, Vol.250 (3), p.323-335

2020

Volltextzugriff (PDF)

Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention

American journal of obstetrics and gynecology, 2014-05, Vol.210 (5), p.471.e1-471.e11

2014

Volltextzugriff (PDF)

The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future

Virchows Archiv : an international journal of pathology, 2018-06, Vol.472 (6), p.885-896

2018

Volltextzugriff (PDF)

Rare cancers: a sea of opportunity

The lancet oncology, 2016-02, Vol.17 (2), p.e52-e61

2016

Volltextzugriff (PDF)

Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status

Modern pathology, 2020-08, Vol.33 (8), p.1595-1605

2020

Volltextzugriff (PDF)

Commentary: novel observations and detailed molecular characterisation of mixed tumours and mesonephric‐like carcinosarcomas by Mirkovic et al. (2023)

Histopathology, 2023-06, Vol.82 (7), p.974-977

2023

Volltextzugriff (PDF)

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

PLoS medicine, 2008-12, Vol.5 (12), p.e232-e232

2008

Volltextzugriff (PDF)

p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification

International journal of gynecological cancer, 2021-06, Vol.31 (6), p.907-913

2021

Volltextzugriff (PDF)

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

The American journal of surgical pathology, 2018-05, Vol.42 (5), p.561-568

2018

Volltextzugriff (PDF)

Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization

Clinical cancer research, 2017-08, Vol.23 (15), p.4086-4094

2017

Volltextzugriff (PDF)

Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome

Modern pathology, 2021-02, Vol.34 (2), p.508-518

2021

Volltextzugriff (PDF)

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors

PloS one, 2009-07, Vol.4 (7), p.e6412-e6412

2009

Volltextzugriff (PDF)

1 – 25 von 465

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(454)
Mit Volltextzugriff
(390)

Publikationsform

Sprache

Englisch
(465)
Japanisch
(126)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Vulval squamous cell carcinoma and its precursors

Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020)

Dr. Naveena Singh, Dec 7 1964 - Oct 5 2023

Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis

Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists

L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile

Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma

The disparate origins of ovarian cancers: pathogenesis and prevention strategies

Ovarian carcinoma pathology and genetics: recent advances

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies

Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma

Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

Interpretation of somatic POLE mutations in endometrial carcinoma

Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention

The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future

Rare cancers: a sea of opportunity

Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status

Commentary: novel observations and detailed molecular characterisation of mixed tumours and mesonephric‐like carcinosarcomas by Mirkovic et al. (2023)

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization

Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors

Suchergebnisse filtern